HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Mariniello, B. Articles by Giacchetti, G. Search for Related Content PubMed PubMed Citation Articles by Mariniello, B. Articles by Giacchetti, G.

Adipose tissue 11ß-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing’s syndrome

¹ Division of Endocrinology and ² Department of Medical and Surgical Sciences, School of Medicine, University of Padua, Via Ospedale 105, 35128 Padua, Italy and ³ Division of Endocrinology, Department of Internal Medicine, Università Politecnica delle Marche, Via Conca 1, 60020 Ancona, Italy

(Correspondence should be addressed to B Mariniello; Email: barbaramariniello{at}yahoo.it)

Objective: To evaluate the expression of 11ß-hydrxysteroid dehydrogenase type 1 (11ß-HSD1) in omental adipose tissue of patients with Cushing’s syndrome and simple obesity, compared with normal weight controls.

Design and methods: We have performed a case-control study and studied omental adipose tissue from a total of 24 subjects (eight obese subjects, ten patients with Cushing’s syndrome due to adrenal adenoma, and six normal weight controls). Body mass index, blood pressure, plasma glucose, plasma insulin, plasma cortisol, urinary free cortisol and post dexamethasone plasma cortisol were measured with standard methods. 11ß-HSD1 mRNA and protein expression were evaluated in real-time PCR and western blot analysis respectively.

Results: 11ß-HSD1 mRNA was 13-fold higher in obese subjects compared with controls (P=0.001). No differences were found between Cushing’s patients and controls. Western blot analysis supported the mRNA expression results.

Conclusions: Our data show the involvement of 11ß-HSD1 enzyme invisceral obesity, which is more evident in severely obese patients than in Cushing’s syndrome patients. The lack of increase of 11ß-HSD1 expression in Cushing’s syndrome could suggest downregulation of the enzyme as a result of long-term overstimulation.

This article has been cited by other articles:

				A. Balachandran, H. Guan, M. Sellan, S. van Uum, and K. Yang Insulin and Dexamethasone Dynamically Regulate Adipocyte 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Endocrinology, August 1, 2008; 149(8): 4069 - 4079. [Abstract] [Full Text] [PDF]